Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor and NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06517433
What this trial is testing

First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b

Who this might be right for
Platinum Resistant Ovarian CancerNon Small Cell Lung Cancer Metastatic
Mersana Therapeutics 62
Early research (Phase 1)Active Not RecruitingNCT05239143
What this trial is testing

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Breast CancerOvarian CancerNon Small Cell Lung Cancer+6 more
Poseida Therapeutics, Inc. 180
Testing effectiveness (Phase 2)Looking for participantsNCT07219576
What this trial is testing

Retifanlimab and Ruxolitinib In Solid Malignancies

Who this might be right for
Non Small Cell Lung CarcinomaRenal Cell Carcinoma
University of California, San Diego 40
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Early research (Phase 1)Ended earlyNCT02080078
What this trial is testing

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Who this might be right for
Non-small Cell Lung CancerAdvanced Solid Malignancies
AHS Cancer Control Alberta 15
Testing effectiveness (Phase 2)Study completedNCT02423343
What this trial is testing

Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma

Who this might be right for
Solid TumorNon-Small Cell Lung Cancer RecurrentHepatocellular Carcinoma Recurrent
Eli Lilly and Company 41
Testing effectiveness (Phase 2)Ended earlyNCT04875806
What this trial is testing

A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsOvarian CancerNon-small Cell Lung Cancer+1 more
NextCure, Inc. 40
Testing effectiveness (Phase 2)WithdrawnNCT04430933
What this trial is testing

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung Cancer
NextCure, Inc.
Testing effectiveness (Phase 2)UnknownNCT02562963
What this trial is testing

Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor

Who this might be right for
Non-small Cell Lung CancerGastric CancerHepatocellular Carcinoma+1 more
Minghui Zhang 120
Early research (Phase 1)Looking for participantsNCT07358806
What this trial is testing

Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorBreast CancerHead and Neck Cancer+3 more
Oscotec Inc. 51
Early research (Phase 1)Not Yet RecruitingNCT07649200
What this trial is testing

Study of SNH-118110 in Advanced Solid Tumors

Who this might be right for
Solid Tumors
ScinnoHub Pharmaceutical Co., Ltd. 240
Early research (Phase 1)Active Not RecruitingNCT02432963
What this trial is testing

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

Who this might be right for
Adult Solid NeoplasmBladder CarcinomaColon Carcinoma+14 more
City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Looking for participantsNCT06848699
What this trial is testing

A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor CancerNon Small Cell Lung Cancer
Shanghai Henlius Biotech 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439292
What this trial is testing

Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT04130516
What this trial is testing

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

Who this might be right for
Solid Tumor, Adult
Linnaeus Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT04720976
What this trial is testing

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorNSCLC
Allist Pharmaceuticals, Inc. 58
Early research (Phase 1)Ended earlyNCT04396340
What this trial is testing

First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b

Who this might be right for
Ovarian CancerNonsmall Cell Lung Cancer
Mersana Therapeutics 31
Next Page